Cargando…
Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes
Patients with diabetes have a higher incidence of bladder cancer; however, the association between thiazolidinedione use and bladder cancer risk has been controversial. We aimed to investigate whether pioglitazone or rosiglitazone use is associated with bladder cancer risk in patients with type 2 di...
Autores principales: | Han, Eugene, Jang, Suk-Yong, Kim, Gyuri, Lee, Yong-ho, Choe, Eun Yeong, Nam, Chung Mo, Kang, Eun Seok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753931/ https://www.ncbi.nlm.nih.gov/pubmed/26871835 http://dx.doi.org/10.1097/MD.0000000000002786 |
Ejemplares similares
-
Diabetes self-assessment score and the development of diabetes: A 10-year prospective study
por: Kim, Gyuri, et al.
Publicado: (2017) -
Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
por: Han, Eugene, et al.
Publicado: (2020) -
Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis
por: Park, Se Hee, et al.
Publicado: (2016) -
Association Between Heme Oxygenase-1 Promoter Polymorphisms and the Development of Albuminuria in Type 2 Diabetes: A Case–Control Study
por: Lee, Eun Young, et al.
Publicado: (2015) -
Urinary N-acetyl-β-d-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes
por: Kim, So Ra, et al.
Publicado: (2016)